Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study
Authors
Keywords
Brain atrophy, Delayed-release dimethyl fumarate, Lesion, MRI, Relapsing–remitting multiple sclerosis
Journal
JOURNAL OF NEUROLOGY
Volume 261, Issue 9, Pages 1794-1802
Publisher
Springer Nature
Online
2014-07-26
DOI
10.1007/s00415-014-7412-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple Sclerosis
- (2012) Ernst-Wilhelm Radue ARCHIVES OF NEUROLOGY
- Advances in Imaging to Support the Development of Novel Therapies for Multiple Sclerosis
- (2012) D H Miller et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study
- (2012) Giancarlo Comi et al. JOURNAL OF NEUROLOGY
- Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
- (2012) Giancarlo Comi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Magnetic Resonance Techniques in Multiple Sclerosis
- (2011) Massimo Filippi ARCHIVES OF NEUROLOGY
- Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
- (2011) Ralf A. Linker et al. BRAIN
- Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
- (2011) Kamran Ghoreschi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The impact of intensity variations in T1-hypointense lesions on clinical correlations in multiple sclerosis
- (2011) RC Tam et al. Multiple Sclerosis Journal
- Effect of BG-12 on contrast-enhanced lesions in patients with relapsing– remitting multiple sclerosis: subgroup analyses from the phase 2b study
- (2011) Ludwig Kappos et al. Multiple Sclerosis Journal
- Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
- (2011) Paul O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
- (2008) Ludwig Kappos et al. LANCET
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
- (2008) R. Zivadinov et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now